Impact Factor
2.69
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.31
313 total citations
h5-index
21
h5 depth signal
Cited share
43.0%
107 of 249
Total citations
313
Citation footprint
Metric signal
1.33
External metric anchor
Self-citation
9.9%
31 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
France
990
Tunisia
89
Switzerland
18
Morocco
15
India
11
Citing Fields of Research
Pharmacology & Toxicology
220
Medical Ethics
157
Substance Abuse
99
Patient Care
83
Allergies
69
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,312
Articles tracked across the journal lifetime
Indexed publication set
249
107 cited publications
Last 12 months
81
6.8 publications/month
Open access share
30.9%
25 OA publications in the last year
Leading citing country
France
990 citing publications
Leading citing field
Pharmacology & Toxicology
220 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v19n6, Nov.-Dec. 1964-
v19n6, Nov.-Dec. 1964-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Substance Abuse
Pharmacology & Toxicology
Medical Ethics
Allergies
Anesthetic & Pain Medicine
Patient Care
Issuing & Sponsoring Bodies
Contributor
Société de thérapeutique et de pharmacodynamie
Contributor
Société française de thérapeutique et de pharmacodynamie
Contributor
Société française de pharmacologie et de thérapeutique
Broad Categories
Therapeutics
Medical Ethics
Substance Abuse
Allergies
Anesthetic & Pain Medicine
Patient Care
MeSH Descriptors
Drug Therapy
Pharmacology
Therapeutics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.therap.2026.09.048
Open DOI
Quality and reliability of antidepressant-related content on Instagram and TikTok
02
03
DOI 10.1016/j.therap.2026.09.047
Open DOI
Physiopathology of severe drug-induced skin reactions
04
DOI 10.1016/j.therap.2026.09.046
Open DOI
Local treatments of psoriasis and atopic dermatitis: from pharmacological targets to meta-analyses
05
DOI 10.1016/j.therap.2026.09.045
Open DOI
Systemic treatments of psoriasis and atopic dermatitis in adults and children: from pharmacological targets to meta-analyses
06
DOI 10.1016/j.therap.2026.09.044
Open DOI
Onset of vitiligo during bimekizumab treatment for psoriasis
07
DOI 10.1016/j.therap.2026.08.002
Open DOI
Behavioral tics following sublingual allergen immunotherapy (OSIRIS): A case report
08
DOI 10.1016/j.therap.2026.09.043
Open DOI
Quand le vaccin déclenche la pustulose : à propos d’une PEAG post-vaccination anti-COVID-19 inactivée
09
DOI 10.1016/j.therap.2026.07.007
Open DOI
Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data
10
DOI 10.1016/j.therap.2026.07.006
Open DOI
Buprénorphine et gestion de la douleur : mise au point clinique et repères pratiques
Bibliographical & Catalog Notes
Also issued online.
Articles in English and French, 2016- .
Organ of the Société de thérapeutique et de pharmacodynamie, 1946-51; of the Société française de thérapeutique et de pharmacodynamie, 1952- .
Vol. 36, no. 1 (1981)19920925 Notice not published Printed on acid-free paper